Rescoll reinforces Applus+ services in medical device testing and increases its presence as a top aerospace partner.
12 June 2023 – Applus+, a global leader in the testing, inspection and certification (TIC) sector, is pleased to announce the acquisition of the entire share capital of Rescoll, a leading materials testing and R&D technological partner based in France.
Founded in 2000 and headquartered in Bordeaux, Rescoll has 170 employees and an annual revenue of €21 million. Its well-equipped laboratories, experts, and renowned capabilities support the development of the medical, aerospace, industry, and energy sectors.
Rescoll is specialised in chemical analysis, mechanical testing, material and process engineering, with deep expertise in adhesives and coatings. It is highly recognised in France for its extensive and accredited testing portfolio and unique qualifications.
With this acquisition, Applus+ strengthens its service portfolio to meet the challenging and growing demands of the medical device and aerospace sectors, positioning itself in top industry hubs, including Germany, France and Spain.
In medical devices, the Laboratories Division extends its services with biocompatibility and mechanical tests on implants and biomaterials. Rescoll also positions Applus+ as a leading partner for the aerospace sector, adding new accreditations and complementing its large and versatile facilities that currently cover the whole testing pyramid, from coupons to full-scale testing.
Mauricio Úbeda, Executive Vice President of the Laboratories Division, says: “Rescoll fits perfectly into our strategic plan, expanding our services in medical devices, a highly attractive end market. This acquisition follows the recently acquired CFI, a renowned Chinese automotive testing laboratory that likewise enables us to expand our network in high growth markets.”
Joan Amigó, Chief Executive Officer of the Applus+ Group, says: “I am delighted that Rescoll has joined Applus+ and I welcome all the employees to our Group. Rescoll represents a strategic acquisition fully aligned with our strategy of acquiring higher-margin businesses. It provides highly technological services linked to sustainability and more environmentally friendly materials for aerospace and other industries.”
José Alcorta, Chief Executive Officer of Rescoll, adds: “With continuous growth since its creation, Rescoll now welcomes an external partner to continue and accelerate its development. In Applus+, we have found the right partner. We will provide Applus+ with expertise in the medical field, as well as know-how in the adhesives and paints industry. These synergies will be further enhanced by the two companies’ shared vision and will enable us to play a role in creating a European leader in the field of testing and certification.”
Applus+ is one of the world’s leading and most innovative companies in the testing, inspection and certification sector. It provides solutions for customers in all types of industries to ensure that their assets and products meet quality, health & safety and environmental standards and regulations.
Applus+ has a broad portfolio of sustainable services that help clients to meet their environmental and social objectives. The Group strategy aligns with the global megatrends of energy transition, electrification and connectivity. Applus+ drives innovation and digitalisation at all levels and invests in the development of proprietary solutions, holding 151 current patents from 34 different families and more than 210 research projects.
Headquartered in Spain and listed on the Spanish stock markets, Applus+ operates in more than 65 countries and employs over 26,000 people. For the full year of 2022, Applus+ reported revenue of €2,050 million, and an adjusted operating profit of €202 million. The total number of shares is 135,867,508.